How much can one injection of romiplostim increase the platelet level?

Romiplostim is a recombinant human thrombopoietin receptor agonist, mainly used to treat patients with chronic immune thrombocytopenia (ITP), especially for cases that are unresponsive to first-line treatment. It promotes platelet production by stimulating the proliferation and maturation of megakaryocytes in the bone marrow. The dose of romiplostim is usually calculated based on body weight, with a starting dose of 1 g/kg μg/kg, administered subcutaneously once a week, and adjusted according to the patient's platelet response.

Regarding"How much platelet value can be raised by one injection?" In fact, there is no fixed answer to this question, because each patient has a different response to the drug, and the extent of the increase is related to the individual's basic platelet level, severity of the disease, immune status, whether it is combined with other diseases, and whether combination therapy is used. Clinical observation shows that most patients can see a significant increase in platelets within one to two weeks after the injection of romiplostim, with the average increase ranging from single digits to more than ten ×10⁹/L, rising to 50-100×10⁹/L or even higher.

Specifically, some patients who are sensitive to drugs may have platelet values increase by 30-50 within a week after injection×10 ⁹/L is even higher, but for some patients with weak responses, it may be necessary to use it continuously for 2-4 weeks or to gradually increase the dose to see obvious effects. Therefore, during treatment with romiplostim, doctors will regularly monitor platelet levels and dynamically adjust the dose based on the results to achieve the ideal therapeutic effect while avoiding the risk of thrombosis caused by excessive platelet levels.

In short, romiplostim has good efficacy in increasing platelet levels, but“How much can be increased with one injection” is not a fixed number, but a process that varies from person to person. Patients should use it under the guidance of a professional hematologist, monitor platelet changes every week, and adjust the dose reasonably to ensure efficacy and reduce the risk of adverse reactions. If the effect is not good, the doctor may consider combining immunosuppressants or switching to other treatment options.

Reference: https://en.wikipedia.org/wiki/Romiplostim